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ABSTRACT 
Objective: The objective the present work was to investigate in vivo and in vitro anti-diabetic potentials of methanol extract of Tephrosia calophylla 
against alloxan-induced diabetes in albino rats.  
Methods: For in vivo evaluation, diabetes was induced in albino rats by administering a single dose of alloxan. The study was designed to test the 
acute effect of methanol extract of Tephrosia calophylla (TCME) to reduce blood glucose in OGTT. The chronic study of 21 d was performed against 
diabetic rats and blood glucose was determined at 1st, 7th, 14th and 21st day. In chronic in vivo study, serum concentrations of insulin, urea, 
creatinine, total cholesterol, triglycerides, ALT and AST were also estimated at 21st day. The in vitro α-glucisidase inhibitory activity and α-amylase 
inhibitory activity were performed and IC50
Results: In OGTT, standard glibenclamide and TCME at 400 mg/kg treated animals have shown significant reduction in blood glucose at 90 min but 
at 120 min, blood glucose level (BGL) was significantly reduced in glibenclamide and TCME at 200 mg/kg and 400 mg/kg treated animals compared 
to diabetic control group. In chronic modelthe methanol extract effectively reduced blood glucose levels (P<0.001) at 14 th and 21
 values of the extract was determined. The glucose uptake by rat hemidiaphragm model was also used 
test potentials of the extract to increase utilization of the glucose by tissues.  
st day of study in 
therapeutic groups and effect was comparable to that of standard. The extract could also significantly (P<0.001) reduce concentrations of SGOT, 
triglycerides (TGs), Total cholesterol (TC) and urea in serum and significantly (P<0.001) increased the insulin level in blood which proves beneficial 
effects of the extract in diabetes. The change in concentrations of SGPT and urea were less significant (P>0.01). In vitro studies, against both 
α −glucosidae and α − amyalase inhibitory activities, extract has shown significant IC50
Conclusion: The results obtained from the present study suggest that, the methanol extract of Tephrosia calophylla possess significant in vivo anti-
diabetic properties against alloxan induced diabetes in rats. The results also suggests that, TCME also possess the significant in vitro anti-dabetic 
potentials.  
 values and it also enhanced glucose utilization by rat 
hemidaphragm.  
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Diabetes mellitus is a pathological condition characterized by 
metabolic alterations leads to hyperglycemia and other complications 
due to defects in secretion of insulin, action or both. There are two 
types of diabetes mellitus: Type I and Type II. Type I is known as 
insulin dependent diabetes mellitus often referred to as juvenile onset 
diabetes characterized by absolute deficiency of insulin due 
destruction of pancreatic cells and the Type II, which is non-insulin 
dependent, usually develops in adults over the age of 40. It has already 
been established that chronic hyperglycemia of diabetes is associated 
with long term damage due to insulin resistance or defect in release of 
insulin from pancreas [1, 2]. It has an adverse effect on carbohydrate, 
lipid and protein metabolism resulting in chronic hyperglycemia and 
abnormality of lipid profile. These lead to series of secondary 
complications including polyurea, polyphasia, ketosis, retinopathy as 
well as cardiovascular disorder [3]. The oral hypoglycemic and other 
synthetic drugs used in diabetes have their own serious adverse 
effects. Hence in spite of the introduction and extensive utilization of 
hypoglycemic agents, diabetes and the related complications continue 
to be a major health problem worldwide, which is affecting nearly 
10% of the population all over the world [4]. In this regard medicinal 
plants continue to be an important therapeutic aid for alleviating 
ailments of humankind such as diabetes mellitus due to their less or 
no adverse effects. Over the last 2500 y, there have been very strong 
traditional systems of medicine such as Ayurvedic, Chinese, and the 
Unani, born and practiced, more in the eastern continent [5]. The 
Tephrosia is a genus of plant which is of Indian origin. The various 
species of Tephrosia are medicinally important and have been proved 
for their several pharmacological activities [6,7], The Tephrosia 
purpurea belongs to the same genus frequently used in traditional 
system, considered to be medicinaly important and proved for many 
health benefits such as anti-diabetic, anti-cancer, anti-ulcer, 
antihyperlipidemic, anti-bacterial and many puropses. The Tephrosia 
calophylla belongs to same also a important component of traditional 
system of medicine ayurveda for the treatment of diabetis but has lack 
of scientific evidence for its antidiabetic potential [8, 9]. Hence it was 
necessary to provide a clear background proof for the beneficial 
property of the plant in diabetes. In this attempt, study had been 
conducted to determine in vitro and in vivo anti-diabetic potentials of 
methanol extract of areal parts of Tephrosia calophylla.  
MATERIALS AND METHODS 
Plant material 
The areal parts of Tephrosia calophyllahave been collected from Sri 
Venkateshwara University, Tirupati, India and dried under shade. The 
leaves were identified and authenticated by Dr. Madhavachetty Asst. 
Prof. Dept. of Botany and specimen (Herbarium number 977) were 
preserved at institute herbarium library. The leaves part were 
separated form other parts, washed, cleaned and dried for further use.  
Preparation of extract 
The shade dried leaves were pulverised into powder and sieved 
through No. 22 mesh. About 350 g (appx.) of coarse powder was 
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subjected to successive solvent extraction using petroleum ether, 
benzene, chloroform and methanol in soxhlet’sapparatus [10]. 
Preliminary phytochemical investigation 
The preliminary phytochemical investigation for the methanolic 
extract of Tephrosia calophylla had been conducted as per procedure 
prescribed by Khandelwal [11]. 
Drugs and chemicals 
All reagents and chemicals used in the study were obtained 
commercially and were of analytical grade. Alloxan was obtained 
from Sigma Laboratory, India and Glibenclamide was procured from 
Aventis Pharma Ltd., India. 
Animals 
The healthy albino wistar male rats (180-220g) were procured 
from Sri Venkateswara Enterprises, Bangalore housed under 
standard conditions of temperature (22±10C), relative humidity 
(55±10%), 12 h light/dark cycles and fed with standard pellet 
diet (Amrut, Pranav Agro Industries Ltd., Sangli, India) and 
water ad libitum. After randomization into various groups and 
before initiation of the experiment, the rats were acclimatized 
for a period of 7 d under above said environmental conditions. 
The experimental protocol has been approved by the 
Institutional Animals Ethics Committee, IJAHSM, Bangalore (Ref. 
no. IJAHSM/IAEC/2014/03) with the permission from 
Committee for the Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA), Ministry of Social Justice and 
Empowerment, Government of India.  
Acute oral toxicity studies 
The OECD guidelines 423 (up and down procedure) were used to 
determine acute oral toxicity for methanol extract of Tephrosia 
calophylla. A starting dose used was 2000 mg/kg body weight p. o. of 
extract (TCME) was administered to 3 male rats, observed for 14 d. 
The experiments were repeated again with the same dose level, 2000 
mg/kg body weight p. o. of extracts for 3 d more, and observed for 14 
d [12].  
Evaluation of in vivo anti-diabetic activity 
Induction of diabetes in experimental animals  
In both acute and chronic models, rats were made diabetic by a 
single intraperitoneal injection of alloxan monohydrate (150 
mg/kg). Alloxan was first weighed individually for each animal 
according to the body weight and then solubilized with 0.2 ml saline 
(154 mmol NaCl) just prior to injection. Two days after alloxan 
injection, rats with plasma glucose levels of>140 mg/dl were 
included in the study. Treatment with plant extracts was started 48 
h after alloxan injection [13-15]. 
Group design 
For both OGTT and chronic study, the animals were divided into six 
groups consisting of six animals in each and all the animals except 
normal (Group I) were induced diabetes by administering a single 
dose of alloxan as explained above. The animal grouping is as 
follows.  
• Group I: Normal control treated with normal saline (10 ml p. o) 
alone, 
• Group II: Diabetic control treated with alloxan and vehicle 
Tween20,  
• Group III: Standard treated alloxan and Glibenclamide 5 mg/kg,  
• Group IV: TCME (Low dose) treated alloxan and methanol 
extract of Tephrosiacalophylla 100 mg/kg, p. o 
• Group V: TCME (Medium dose) treated alloxan and methanol 
extract of Tephrosiacalophylla200 mg/kg, p. o 
• Group VI: TCME (High dose) treated alloxan and methanol 
extract of Tephrosiacalophylla400 mg/kg, p. o 
Oral glucose tolerance test [OGTT] 
At third day after inducing diabetes in animals, the suspensions of 
standard drug glibenclamide and extract were prepared using 
Tween20 as suspending agent and administered to respective 
animals with help of oral feeding tubes according to below protocol 
(Koteeswara Rao et al., 2006). One hour after administration of 
extract and glibenclamide, the blood samples were collected from all 
six group of animals and the basal blood glucose was determined. All 
rats were fed with oral glucose solution (2g/kg) and blood samples 
from each rat were collected at different intervals of 30 min, 60 min, 
90 min and 120 min and estimated for blood glucose using 
Glucometer (Acucheck) [16-18]. 
Chronic study model 
In a chronic study also animals were divided into six groups as 
above. The standard drug glibenclamide and methanol extract of 
Tephrosia calophylla were administered to respective animals 
according to their body weights from 1st day to 21st
Blood samples from each rat were collected on day 1
 d). 
st, 7th, 14th and 
21st
Collection of blood sample and estimation of parameters 
 and estimated for blood glucose. On last day of study blood 
samples had been also estimated for insulin, cholesterol, 
Triglycerides, creatinine, urea, ALT and AST [19-20].  
Blood samples were collected from retro-orbital plexus under mild 
ether anesthesia from rats. The blood glucose estimated using 
Glucometer (Accucheck) On the 21st
Evaluation of in vitro anti-diabetic activity 
 day, serum was separated from 
blood samples and analyzed serum for cholesterol, triglycerides by 
enzymatic DHBS colourimetric method and ALT, AST, urea, 
creatinine and insulin were estimated using standard kits.  
α-Glucosidase inhibitory assay 
This assay was carried out to investigate the in vitro inhibitory 
activity of TCME on sucrase and maltase (α-glucosidases). Although 
α-glucosidase isolated from yeast is extensively used as a screening 
material for a-glucosidase inhibitors, the results did not always 
agree with those obtained in mammals. Hence in present study small 
intestine homogenate of aalbino mouse was used as an a-glucosidase 
solution since it speculated that it would better reflect the in vivo 
state. The inhibitory effect was measured by slightly modifying the 
method used by “Dahlqvist” [19]. After 20 h of fasting, part of the 
animals’ small intestine immediately below the duodenum and 
immediately above the cecum was cut, rinsed with ice-cold saline, 
and homogenized with 12 ml of maleate buffer (100 mmol, pH 6). 
The homogenate was used as an α-glucosidase solution. The assay 
mixture consisted of 100 mmol maleate buffer (pH 6), 2% (w/v) of 
each sugar substrate solution (100 ml), and the sample extract (20-
640 μg/ml). The mixture was preincubated for5 min at 37 °C, and 
the reaction was initiated by adding crude α-glucosidase solution 
(50 ml), followed by incubating the mixture again for 10 min at 37 
°C. The amount of glucose released in this reaction was determined 
by a commercially available glucose estimation kit (Span Diagnostic 
Ltd., Mumbai, India). The amount of glucose produced by the 
positive control (GCP), glucose production value in the blank (GCB) 
and amount of glucose produced by the addition of TCME (GCT) 
were recorded [21-23]. The rate of carbohydrate decomposition was 
calculated as a percentage ratio to the amount of glucose obtained 
when the carbohydrate was completely digested. The rate of 
prevention was calculated by the following formula:  
Inhibition rate (%) = GCP-GCT-GCT X100 
GCP 
α-amylase inhibitory assay 
Test samples of TCME (6.25, 12.5, 25, 50, 100, 200 mg/ml) and 
nojirimycin (6.25-200 μg/ml)] of 500 ml concentration were added 
to 500 ml of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M 
sodium chloride) containing 0.5 mg/ml porcine pancreatic α-
amylase solution (Sigma Chemical Co., St. Louis, MO, USA) and were 
incubated at 25 °C for 10 min. After the preincubation, 500 ml of 1% 
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starch solution in 0.02 M sodium phosphate buffer (pH 6.9 with 
0.006 M sodium chloride) was added to each tube at prespecified 
intervals. The reaction mixtures were then incubated at 25 °C for 10 
min. The reaction was stopped by adding 1 ml of 3,5-dinitrosalicylic 
acid color reagent. The test tubes were then incubated in a boiling 
water bath for 5 min and cooled down to room temperature. The 
reaction mixture was then diluted after adding 10 ml of distilled 
water and absorbance was measured at 540 nm [21-23]. 
% inhibition = Abs(Control)(540)-Abs (Extract)(540) 
Abs (Control)(540) 
 Glucose uptake by isolated rat hemidiaphragm 
Glucose uptake by rat hemidiaphragm was estimated according to 
earlier works [27, 28], but with some modifications. Four groups, 
with each group containing six graduated test tubes (n=6), were 
considered as follows:  
• Group 1: 2 ml of Tyrode solution with 2% glucose. 
• Group 2: 2 ml of Tyrode solution with 2% glucose and regular 
insulin solution (Novo Nordisk; 0.62 ml of 0.4 U/ml). 
• Group 3: 2 ml of Tyrode solution and 1.38 ml of TCME (0.1% v/v). 
• Group 4: 2 ml of Tyrode solution with 2% glucose and regular 
insulin (0.62 ml of 0.4 U/ml) solution and 1.38 ml of TCME 
(0.1% v/v). 
The volumes of all the test tubes were made up to 4 ml by adding 
distilled water to match the volume of the test tubes in Group 4. A 
total of 12 albino rats were fasted overnight and decapitated. The 
diaphragms were quickly dissected with minimal trauma and 
divided into two halves. Two diaphragms from the same animal 
were not used for the same set of experiments. Six diaphragms were 
used for each group. The hemi diaphragms were placed in test tubes 
and incubated for 30 min at 37 °C in an atmosphere of 100% oxygen 
and were shaken at a speed of 140 cycles/minute. Glucose uptake 
per gram of tissue was calculated as the difference between the 
initial and final glucose content in the incubated medium [24]. 
Statistical analysis 
The data obtained in the study was analyzed by ANOVA and post hoc 
Dunnet’s t-test using Graphpad prism5 software. All the values were 
expressed as mean±standard error of the mean (SEM).  
RESULTS 
Preliminary phytochemical study 
The percentage yield of the TCME was found to be 7.84% w/w. The 
preliminary phytochemical investigation for the methanol extract of 
Tephrosia calophylla reveals the presence of polyphenols, flavonoids, 
tannins, steroids, alkaloids and carbohydrates in the leaves.  
Acute toxicity studies 
The methanol extract was safe up to a dose of 2000 mg kg-1 b.w. and 
caused neither mortality nor any signs of clinical abnormality in the 
tested animals during the observation period of 14 d after 
administration of the highest dose. There was no considerable 
change in body weight before and after treatment of the experiment 
and no signs of toxicity were observed. When the experiments were 
repeated again with the same dose level, 2000 mg/kg body weight p. 
o. of extracts for 3 d more, no changes were observed for 14 d. As 
per the results obtained in an acute oral toxicity study doses were 
selected as 100, 200 and 400 mg/kg on the ratio 1/20th, 1/10th and 
1/5th
Evaluation of in vivo anti-diabetic activity 
 respectively.  
Oral glucose tolerance test 
In acute study (OGTT) animals in a diabetic alone group have shown 
significantly elevated their blood glucose level through entire study 
when compared to normal animals. But treatment with standard 
drug glibenclamide and methanolic extract (200 mg/kg and 400 
mg/kg) of Tephrosia calophylla could able to improve utilization of 
oral glucose by animals and significantly (P<0.001) reduced blood 
glucose level in therapeutic groups after 60 min and 120 min. The 
results of OGTT have shown in [table 1]. 
  
Table 1: Effect of methanol extracts of Tephrosia calophylla on blood glucose OGTT 
Treatment Concentration of blood glucose (mg/dl) 
0 Min 30 Min 60 Min 90 Min 120 Min 
Normal Control 81.17±1.352 133.5±1.839 129.2±1.740 105.8±1.956 79.67±2.789 




174.7±2.963 279.2±3.911 199.7±3.442 158.8±4.729 119.8±4.936 
TCME 100 mg/kg 170.7±3.263 273.3±3.584 255.5±2.643 226.3±3.499 182.8***±5.108 
TCME 200 mg/kg 169.2±6.488 269.3±4.341 224.0±3.856 180.3***±3.703 157.2***±6.467 
TCME 400 mg/kg 167.2±4.354 268.8±5.683 179.8**±1.470 150.0***±3.109 114.0***±4.960 
Values are mean±SEM n=6 symbols represent statistical significance, nsp>0.05, *p<0.05, **p<0.01, ***p<0.001 vs diabetic 
control., nsp>0.05,+p<0.05,++p<0.01,+++
 
Determination of chronic anti-diabetic activity  
In chronic study, the blood glucose level was significantly (P<0.001) 
increased in diabetic control animals compared to normal animals 
due to the induction of glucose. While treatment with glibenclamide 
and TCME extract at 200 mg/kg and 400 mg/kg could significantly 
(P<0.001) reduced blood glucose concentrations compared to 
diabetic control animals at 14
p<0.001 normal control vs positive control. 
th and 21st
The total cholesterol, triglycerides, urea and creatinine levels in the 
blood were significantly (P<0.01) increased in diabetic compare to 
normal animals. But reduction in the serum cholesterol, 
triglycerides, urea and creatinine concentration was observed in 
glibenclamide and TCME (200 mg/kg 400 mg/kg) treated animals 
when compared to diabetic control. It is found that there is no 
significant (p>0.01) change in AST and AL T levels in diabetic alone 
compare to normal animals and also no significant change was observed 
therapeutic animals treated with glibenclamide and TCME when 
compare to diabetic animals [table 3]. 
Evaluation of in vitro anti-diabetic activity 
α-Glucosidase inhibitory activities 
 day of the study [table 2]. 
The significant (P<0.001) decline of serum insulin was found in 
diabetic control animals compare to normal animals due to the 
administration of alloxan. In animals treated with glibenclamide and 
TCME (200 mg/kg and 400 mg/kg) there was significant (P<0.001) 
increasing in blood insulin level compared to diabetic control 
animals and the results were comparable to normal animals.  
An in the vitroα-Glucosidase inhibitors potential of methanol extract 
of Tephrosia calophylla was examined. The half maximal inhibitory 
concentration (IC50) values of sucrase and maltase inhibitory 
activities were found to be399.733μg/ml and 78.412μg/ml 
respectively. The results in that TCME have shown strong activity in 
a dose-dependent manner and is thus inferred to be an effective α-
glucosidase inhibitor [table 4 and fig. 1 and 2]. 
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Table 2: Effect of methanol extracts of Tephrosia calophylla in the chronic study 
Treatment The concentration of blood glucose (mg/dl) 
DAY 1 DAY 7 DAY 14 DAY 21 
Normal Control 147.8±2.301 135.3±1.476 136.2±2.442 133.2±3.506 
Diabetic Control 241.6+++ 236.2+±2.113 ++ 231.0±2.664 +++ 236.7±2.033 +++
Standard (Glibenclamide 5 mg/kg) 
±3.159 
234.2±6.290 211.8±4.143 171.5±3.374 145.2±1.740 
TCME 100 mg/kg 238.5±6.329 223.5±5.898 217.2*±2.937 205.2*±4.840 
TCME 200 mg/kg 236.7±4.958 218.3±3.575 190.2**±4.324 177.7***±2.848 
TCME 400 mg/kg 226.8±7.109 198.7±5.524 175.8***±2.330 140.2***±3.637 
Values are mean±SEM, n=6 symbols represent statistical significance. nsp>0.05, * p<0.05, ** p<0.01, ***p<0.001 vs diabetic 
control., nsp>0.05,+p<0.05,++p<0.01,+++
 
p<0.001 normal control vs positive control. 
Table 3: Effect of methanol extracts of on serum parameters Tephrosia calophyllaon blood glucose in chronic study 
















Normal Control 136.7±2.499 80.02±2.223 105.1±1.542 0.5417±0.01647 31.06±1.703 63.30±1.273 129.7±1.978 
Toxic Control 66.50+++ 108.4±1.910 +++ 131.8±2.724 +++ 1.464±2.432 +++ 72.57±0.05661 +++ 62.37±1.372 ±1.302 134.0±2.385 
Standard 
(Glibenclamide) 
137.7***±2.741 79.57***±3.075 100.9***±2.994 0.6318***±0.03644 35.48***±1.855 63.09***±0.7677 126.7±2.212 
TCME 100 mg/kg 93.50±3.631 106.2±3.444 126.4±5.142 1.181±0.03347 63.07±0.9838 62.34±2.356 132.4±2.832 
TCME 200 mg/kg 107.2**±3.468 92.27**±2.214 110.0**±2.864 0.9072**±0.04888 45.52**±0.5945 62.65±1.392 132.6±1.525 
TCME 400 mg/kg 138.7***±2.813 77.58***±2.355 105.1***±5.167 0.5757***±0.01777 32.33***±1.998 62.26±2.043 122.6±1.603 
Values are mean±SEM, n=6 symbols represent statistical significance. nsp>0.05, * p<0.05, ** p<0.01, ***p<0.001 vs diabetic 
control., nsp>0.05,+p<0.05,++p<0.01,+++
 
p<0.001 normal control vs positive control. 
Table 4: Effect of TCME on α-glucosidase (Sucrase and maltase) and amylase inhibitory activity 
Treatment IC50 values (μg/ml) 
α-Glucosidase (Sucrase) α-Glucosidase (Maltase) α-Amylase 
TCME 399.733 78.412 135.042 
Acarbose 103.425 98.33 -- 
Nojirimycin -- -- 37.258 
 
 
Fig. 1: Effect of TCME on α-glucosidase (Sucrase) and amylase 
inhibitory activity 
 
α-Amylase inhibitory activities 
To amylase inhibitory effect of methanol extract of Tephrosia 
calophyllawas tested to determine the ability of the drug to reduce 
postprandial glucose. In this study, TCME exhibited strong inhibitory 
activity against α-amylase with IC50
The results of the present study suggest glucose uptake 
(milligrams/gram tissue weight) in an isolated rat hemidiaphragm 
muscle in the presence of insulin (0.4 U/ml) and TCME (0.1% w/v). 
The results of this experiment indicate that the addition of TCME to 
the incubation media (Tyrode solution) caused a significant increase in 
glucose uptake by the rat hemi diaphragm and was found to be less 
effective than insulin. Moreover, TCME seemed to be more effective in 
enhancing peripheral glucose uptake in rat hemi diaphragm in the 
absence of insulin. Treatment withTCME (0.1% w/v) also elicited a 
significant increase (p<0.001) in glucose uptake by the isolated rat 
hemidiaphragmwhen compared with the control groups. These results 
show that treatment with insulin or TCME alone for 30 min produced 
a significant increase in glucose uptake by 3.37-and 2.92-times, 
respectively. Addition of both insulin and TCME to the incubation 
media exerted the rate by 3.01-times, an increase of glucose uptake in 
rat hemi diaphragm compared with untreated control groups but 
there was no much significant increase compared insulin alone treated 
group. The glucose uptake by rat hemi diaphragm was significantly 
more in all the groups tested when compared with the control group. 
 
 of 135.042μg/ml, which is 
comparable with positive controls [table 4 and fig. 3].  
Effect on peripheral glucose uptake 
 
Fig. 2: Effect of TCME on α-glucosidase (maltase) and amylase 
inhibitory activity
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Fig. 3: Effect of TCME on amylase inhibitory activity 
 
Table 5: Effect of TCME on glucose uptake by isolated rat 
hemidiaphragm 





Values are mean±SEM (n Z 6)., ** p<0.01 as compared with control 
 
DISCUSSION 
Diabetes mellitus is a serious pathological condition due to 
disturbances in the metabolism of nutrients such as carbohydrates, 
amino acids and lipids. It is a multifactorial disorder with increasing 
incidence throughout the world [25]. The Alloxan a diabetogenic 
used in the present study, a cyclic urea derivative, which selectively 
destroys insulin-producing pancreatic cells by free radical-mediated 
damage and when administered to rodents cause an insulin-
dependent diabetes mellitus [26] and has been widely used for the 
induction of experimental diabetes in animals. The organ toxicities 
are serious complications of diabetes such as neuropathy, 
retinopathy, nephropathy, hyperlipidemia and various 
cardiovascular diseases. The objective of the present research was 
to evaluate in vivo anti-diabetic potentials of Tephrosia villosa 
against alloxan induced diabetes in rats and also to evaluate in vitro 
anti-diabetic properties of Tephrosia villosa byα-amylase and α-
glucosidase inhibitor activity and glucose uptake by rat 
hemidiaphragm method.  
In the current study, 2 set of experiments were designed to explore 
the in vivo antidiabetic potential of methanolic extract of Tephrosia 
calophylla leaves against alloxan-induced diabetic rat model. The 
study was designed to evaluate the acute and chronic effects of 
extract in animals induced with diabetes and to compare the results 
with anti-diabetic potentials of reference drug glibencalmide. In the 
present study, the acute effect of the extract was studied by Oral 
Glucose Tolerance Test (OGTT). For the chronic study, we have 
made the animals diabetic by administering Alloxan and treated the 
animals with varying doses of extract for 21 d. The blood glucose 
level in animals was estimated at 1st, 7th, 14th and 21st
The oral glucose tolerance test is performed to study the acute 
effects of extract in diabetic animals and it based on the ability of the 
body to utilize or tolerate the glucose load administered orally [24, 
25]. In OGTT, induction of diabetes in toxic control rats resulted in 
increased concentration of blood glucose due to the inability of the 
system to utilize glucose in the absence of insulin. But in TCME and 
glibenclamide treated therapeutics animals blood glucose level was 
significantly reduced than the control group which clearly shows the 
ability of the extract to increase the utilization of the glucose by cells 
and tissues.  
 day of the 
study to evaluate the potency of the extract in clearing blood glucose 
in animals induced with diabetis. In additionally, we evaluated 
methanolic extract of Tephrosia calophylla leaves for the 
enhancement of insulin secretion and hence ability to lower the 
blood glucose level in diabetic rats by estimating the concentration 
of insulin in the blood. We have also studied the potentials of the 
extract to lower the diabetic complications by assessing the lipid 
profile, liver and kidney function tests. For the evaluation of lipid 
profile, concentrations of total serum cholesterol and triglycerides 
were estimated. The liver enzymes alanine transferase and aspartate 
transferase were estimated to study the hepatic function and blood 
urea and creatinine were estimated to study the renal function. The 
in vitro study was also conducted to evaluate the extract against α-
glucosidase and α-amylase inhibitory effects and also by glucose 
utilization by skeletal muscle.  
In chronic study, diabetes was induced in all animals except normal 
group by administering alloxan before three days of study. Hence 
there was a significant decrease in insulin secretion in diabetic 
animals due to the destruction of pancreatic cells which resulted in 
decreased utilization of glucose and hence the blood glucose level 
was elevated. But in therapeutic groups treated with standard drug 
glibenclamide, TCME (200 mg/kg and 400 mg/kg), a significant 
increase in insulin release and subsequent decrease in blood glucose 
concentration was found.  
The diabetes mellitus is a chronic metabolic disorder and it is also 
associated with several secondary complications such as 
hyperlipidemia, atherosclerosis, hypertension, diabetic 
nephropathy, diabetic neuropathy and diabetic ketoacidosis. 
Hyperlipidemia is one of such common complication of diabetes 
which is characterized by increase in serum total cholesterol (TC), 
triglycerides (TG), LDL and VLDL. The azotemia is a condition which 
is due to the accumulation of nitrogenous waste products like urea 
and creatinine in blood and usually found during diabetic 
nephropathy [27, 28]. 
Accelerated Coronary and peripheral vascular atherosclerosis is one 
of the most common and serious chronic complications of long-term 
diabetes mellitus. Along with other risk factors such as 
hypertension, smoking, obesity etc., increasing importance has been 
given to secondary hyperlipidemias in the causation of accelerated 
atherosclerosis. Hyperlipidaemia as a metabolic abnormality is 
frequently associated with diabetes mellitus. The most characteristic 
lipid abnormality in diabetics is hypertriglyceridemia, with or 
without an associated increase in plasma cholesterol [29]. 
In our present study administration of alloxan in control animals 
caused elevation of serum cholesterol, triglycerides, and urea as a 
consequence of secondary complications of diabetes. In animals of 
therapeutic groups treated with TCME (200 mg/kg and 400 mg/kg) 
have shown a significant reduction in above serum parameters. 
The association between liver disease and diabetes mellitus is well 
known, the overall prevalence being significantly higher than that 
expected by a chance association of two very common diseases [20, 
31]. But in the present study, there were no significant changes or 
elevation of the liver enzymes AST and ALT found in any group of 
animals including diabetic control animals. 
The high blood sugar levels can damage to the fine blood vessel 
walls in the kidney filters, and these filters become leaky. The 
earliest sign of diabetic damage to kidneys is protein in the urine. 
[32]. In the present study, the concentration of blood urea was 
estimated to evaluate renal function in diabetic animals. In control 
animals treated with alloxan alone, there was a significant increase 
in blood urea and creatinine level whereas chronic treatment with 
our methanol extracts for 21 d could able to normalize blood urea 
and creatinine concentration in test animals and the results were 
comparable to the standard group treated with glibenclamide.  
One of the therapeutic approaches for diabetes is inhibition of 
carbohydrate-hydrolyzing enzymes, such as α-amylase and α-
glucosidase to prevent the absorption of glucose from GIT and 
thereby a decrease in the postprandial hyperglycemia [32, 33]. α-
Glucosidases are enzymes that catalyze the absorption of digested 
glucose from dietary polysaccharides in the small intestine. The α-
glucosidase inhibition by TCME was evaluated by determining the α-
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glucosidase inhibitory activity using 4-Nitrophenyl-b-D-
glucopyranoside-uronic acid (pNPG) as the reaction substrate. The 
crude enzyme solution prepared from a mouse’s small intestine was 
used as a source of α-glucosidases, sucrose and maltase. The 
inhibition of α-Glucosidases can be the useful mechanism to block 
the absorption of dietary carbohydrates and suppresses 
postprandial hyperglycemia [33, 34]. In the present study the TCME 
shown significantα-glucosidase and α-amylase inhibitory activity 
but it is unclear whether the mechanism of inhibition of α-amylase 
and α-glucosidase by TCME is due to the competitive and 
noncompetitive method. The fact that α-amylase and α-glucosidase 
showed different inhibition kinetics seemed to be due to structural 
differences related to the origins of the enzymes [35]. However, the 
inhibition rate for α-glucosidase was close to that of acarbose, but 
the inhibition rate for α-amylase was obviously lower than that of 
nojirimycine. This indicated that TCME was a strong inhibitor for α-
glucosidase with mild inhibitory activity against α-amylase. The 
inhibition of α-glucosidase, together with α-amylase by TCME, is 
considered to be an effective strategy for the control of diabetes by 
diminishing the absorption of glucose [36]. Severe postprandial 
hyperglycemia commonly experienced by patients with diabetes 
could be prevented if the rate of glucose uptake from the intestine 
into the circulation could be reduced by inhibiting carbohydrate 
digestion and absorption. Skeletal muscle represents 30-40% of the 
total body weight and seems to be one of the most important target 
tissues for the action of insulin and for the uptake of glucose at the 
peripheral level [37]. It is a well-known fact that insulin and anti-
diabetic drugs promote glucose uptake by peripheral cells and 
tissues [35]. Another important finding of this work is that TCME 
possesses considerable insulin-like properties, as evidenced by the 
enhancement of glucose uptake in the diaphragm, which represents 
muscle cells that are a major site of insulin-mediated glucose 
disposal. Pieces of hemidiaphragm were incubated with different 
concentrations of TCME and insulin for 30 min. The estimation of 
glucose content in rat hemidiaphragm is a commonly used and a 
reliable method for the in vitro study of peripheral uptake of glucose. 
In addition, TCME significantly enhances the uptake of glucose by 
isolated hemidiaphragm and is found to be less effective than 
insulin. It appears that TCME has direct peripheral action. The 
control value of glucose uptake by rat hemidiaphragm corresponds 
with those of earlier findings [38-40].  
Although the exact mechanism of action of alloxan is not fully 
understood, evidence indicates that the alloxan causes pancreatic β cell 
damage followed by insulin deficiency and diabetes mellitus [41-45]. 
In the present, in vivo study, the extract had been successful to 
increase insulin secretion and to maintain the normal glucose level 
in the therapeutic animals. In in vitro investigation, the TCME has 
shown its potency to reduce insulin resistance by increasing the 
utilization of glucose by tissues. The TCME also exhibited its 
potentials inhabiting GIT enzymes to prevent post-prandial 
hyperglycemia.  
CONCLUSION 
The methanol extract of Tephrosia calophylla possesses significant in 
vivo antidiabetic activity in the alloxan-induced diabetic animal 
model. The results of the present study also suggest that methanol 
extract of Tephrosia calophylla could inhibit in vitro α-glucosidase 
and α-amylase and also significantly increase glucose utilization by 
skeletal muscle. But further investigation is needed to isolate and 
determine the individual components present in Tephrosia 
calophylla that may be responsible for these beneficial effects to 
improve in health conditions associated with diabetes mellitus. 
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